Purpose: The study sought to assess the frequency and prognostic value of hyperattenuating adrenal glands on contrast-enhanced computed tomography (CT) scans of surgical intensive care unit (ICU) patients with acute clinical deterioration. Methods: Eighty-eight consecutive ICU patients (63.2 AE 14.5 years of age) were included in this retrospective analysis. All patients underwent biphasic contrast-enhanced CT due to an acute clinical deterioration. Hyperattenuation of the adrenal glands was assessed subjectively and objectively. Subjective presence or absence of hyperattenuating adrenal glands was assessed by 2 blinded radiologists (J.B. and R.S.L.) in consensus. Hounsfield units (HU) were measured in the adrenal glands and in the inferior vena cava. Objective hyperattenuation was defined as HU (adrenal glands) > HU (inferior vena cava) with a 15-HU threshold. Death within 14 days following CT was set as endpoint and acquired from electronic patient data.
P < 0,05). On note une forte corr elation entre les analyses subjective et objective (P < 0,05). Conclusions : L'hyperatt enuation des glandes surr enales dans les TDM avec injection de produit de contraste chez les patients des unit es de soins intensifs pr esentant une d et erioration clinique s ev ere est associ ee a un haut taux de mortalit e et pourrait servir de marqueur pronostique de l'issue pour les patients. Ó 2016 Canadian Association of Radiologists. All rights reserved. The adrenal glands are located in the retroperitoneum and consist of the cortex and medulla. The adrenal medulla is part of the sympathetic nervous system and produces catecholamines [1] .
In case of hypotension, caused for example by an acute trauma or severe illness, these hormones are secreted as a reflex to nervous stimulation to counteract reduced blood flow to the brain, heart, and muscles [2] . Hence, marked contrast enhancement of the adrenal glands has been described as part of the hypoperfusion complex [3, 4] .
Normally the density of the adrenal glands in contrastenhanced computed tomography (CT) equals the density of other solid abdominal organs such as liver or spleen and is decreased compared to the inferior vena cava (IVC). Density measurements of the adrenal glands are often performed to evaluate adrenal masses [5] , but only a few studies have focused on adrenal enhancement in critically ill patients [4, 6] . In a recent study, Schek et al [6] demonstrated an association of hyperattenuating adrenal glands with a higher mortality in polytraumatized patients, indicating that hyperattenuation of the adrenal glands might be considered as a predictor of poor clinical outcome. According to our experience, contrastenhanced CT frequently reveals hyperattenuating adrenal glands in intensive care unit (ICU) patients.
The purpose of the present study was to evaluate the prognostic value of hyperattenuating adrenal glands in ICU patients undergoing CT examinations due to severe clinical deterioration.
Material and Methods

Patients and Data Collection
This retrospective study was approved by the local ethics committee. Eighty-eight consecutive ICU patients (60 men, 28 women, 63.2 AE 14.5 years of age) who underwent contrastenhanced abdominal CT in arterial and venous phase between January 2010 and May 2011 were included in this analysis. There were no exclusion criteria. Reasons for admittance to surgical ICU are shown in Table 1 . CT examinations were performed for the evaluation of acute complications like bleeding, acute respiratory distress syndrome or acute deterioration in course of an infection (Table 1) . Twelve patients did not undergo surgery prior to ICU admission and were admitted due to terminal cancer stage (n ¼ 3), severe intoxication (n ¼ 1), trauma (n ¼ 2), planned heart transplantation (n ¼ 1), or septic shock (n ¼ 5).
CT Protocol
All CT examinations were performed on a multidetector CT scanner (Emotion 6, Siemens AG Healthcare, Forchheim, Germany). Image acquisition parameters were as follows: tube voltage: 110 kV, pitch: 1, reference tube current time product: 170 mAs. Contrast medium (100 mL; Accupaque 300, GE Healthcare, Munich, Germany) was injected using a power injector (Nemoto Dual Shot, MMS Medicor Medical Supplies GmbH, Kerpen, Germany). Contrast medium injection was routinely performed with 3e4 mL/s, depending on the venous access. Contrast medium injection was followed by a saline flush (40 mL) in all patients. All CT examinations were performed both in the arterial and venous phase. The arterial phase was started using bolus trigger technique with a threshold of 100 Hounsfield units (HU) in the descending aorta. The venous phase was performed 70 seconds after the arterial phase. All examinations were performed at 110 kV and automated tube current modulation was activated in all scans (CAREDose 4D, Siemens AG, Healthcare Section).
Subjective Image Analysis
CT examinations were retrospectively reviewed by 2 radiologists (J.B. and R.S.L.) with 2e8 years of experience in interpreting abdominal CT, who were blinded to patients' clinical data. Subjective evaluation was performed on a PACS workstation (Sectra Medical Systems GmbH, Link-€ oping, Sweden). Attenuation of the adrenal glands was compared to the attenuation of the IVC. In all cases, the arterial and venous phase images were evaluated. Image analysis was performed on 2.5 mm and 5 mm slices and window modulation was to the discretion of the readers. Both readers reviewed at all images together and came to a decision in consensus. Patients were divided into 2 groups (Group A subj : hyperattenuation of the adrenal glands; Group B subj : no hyperattenuation of the adrenal glands).
Objective Image Analysis
For quantitative analysis, HU were determined in the confluence of both adrenal limbs and in the IVC using region-of-interest measurements in the 2.5 mm axial CT images, as reported by previous studies [4, 6] . All measurements were performed in greatly enlarged images to avoid adjacent fat. Measurements were performed on a PACS workstation (Sectra Medical Systems GmbH) in the arterial phase on 2.5 mm slices. A threshold of 15 HU was used to define hyperattenuation. According to the region-of-interest measurements patients were assigned to 2 groups: for Group A obj , density of adrenal glands (HU) > (density of the IVC) þ 15 HU; for Group B obj , density of adrenal glands (HU) (density of the IVC) þ 15 HU.
Outcome Analysis
Death within 14 days following the CT scan was set as the primary endpoint. The patients' clinical history was collected from the electronic hospital information system. The duration of hospitalization on the ICU prior to CT scans, between latest surgery and the CT scan, and between the CT scan and death in patients who deceased within 14 days were obtained. Status of invasive ventilation and laboratory parameters of kidney function (creatinine), inflammation (C-reactive protein and leukocytes), and anemia (hemoglobin) at the time of the CT examination were obtained. Final diagnosis was obtained by reviewing the abdominal CT scan and additional CT scans of the same day, if available.
Statistical Analysis
Microsoft Excel (Microsoft Cooperation, Redmond, WA, USA) and IBM SPSS Statistics 21 for Windows (SPSS, Chicago, IL, USA) were used for data analysis. All data are given as mean AE SD. Ninety-five percent confidence interval (CI) is provided. Statistical significance was defined as P < .05. Normal distribution was tested with a Kolmogorov-Smirnov test. Independent Student t test was used for all normally distributed variables. Mann-Whitney U test was performed as a nonparametric test. A chi-square test was used to analyse differences between groups. Correlations were assessed with Spearman rank-order-correlation. Figure 1 ) and adrenal glands without hyperattenuation ( Figure 2 ).
Results
Subjective Image Analysis
Objective Image Analysis
Thirty-one patients (35.2%; 95% CI, 26.1%e45.6%; 20 men, 11 women, 68.1 AE 21.7 years of age) were assigned to There was a good agreement between subjective and objective analysis (r ¼ 0.61; P < .001).
Patient Outcome
In patients that died within 14 days, there was no significant correlation between density of the adrenal glands and time to death (r ¼ À0.3; P ¼ .06). Furthermore, time interval between CT scans and death in those patients who deceased within 14 days following the CT scan did not differ significantly between Group A subj and Group B subj and between Group A obj and Group B obj (P ¼ .2 and P ¼ .8) ( Table 2) .
Invasive ventilation was significantly more frequent in patients with hyperattenuating adrenal glands whereas patient characteristics such as age and gender and laboratory parameters of kidney function, inflammation, or anemia were comparable between both groups ( Table 3 ).
Discussion
Although hyperattenuation of the adrenal glands is a common known sign in contrast-enhanced abdominal CT, to our knowledge the prognostic impact of hyperattenuating adrenal glands in ICU patients with an acute and severe clinical deterioration has not been investigated so far. We have demonstrated an association between the presence of hyperattenuating adrenal glands and a poor clinical outcome in these patients. Half of the ICU patients with subjective hyperattenuation of the adrenal glands deceased within 14 days after CT examination compared to only 16% of those patients that did not exhibit hyperattenuation of the adrenal glands in the initial CT examination.
Only a few studies have investigated the impact of hyperattenuating adrenal glands on patients' outcome. Schek et al [6] demonstrated significantly higher mortality in patients with hyperattenuation of the adrenal glands following major trauma. This is in accordance to our results and overall, these findings indicate that hyperattenuating adrenal glands can be considered as a prognostic marker of poor clinical outcome in severely ill patients.
Marked enhancement of the adrenal glands has been reported as part of the CT hypotension complex, which can be associated with head and spine injury, septic shock, bacterial endocarditis and diabetic ketoacidosis [6, 7] . The stress due to circulatory dysfunction, centralization, and undersupply of organs with necessary nutrients leads to reflex stimulation of the hypothalamus-pituitary axis. Centralization leads to vasoconstriction and reduced blood flow to the abdominal organs. The preserved blood flow to the adrenal glands to maintain function is believed to lead to the marked enhancement in contrast-enhanced CT examinations [2, 4, 6, 8] .
Our results are in contrast to prior studies assessing adrenal enhancement in patients with hypovolemic shock [8e15]. For example, in a study by Kanki et al [15] mean adrenal enhancement did not serve as a prognostic marker for patients with hypovolemic shock as there was no significant difference in the outcome between patients with and without hypovolemic shock following trauma. This disagreement might be attributed to differences in the study design. Although these prior studies have only included patients with hypovolemic shock [7, 15] , our study included patients undergoing CT due to an acute clinical deterioration irrespective of the presence of hypovolemic shock.
To assess objective hyperattenuation, O'Hara and Donnelly [4] and Schek et al [6] compared the attenuation of the adrenal glands to the adjacent vessels including the IVC. CT examinations in these previous studies were performed in an early venous phase (40e60 seconds after contrast material application). This coincides with prior results of Li et al [14] , who demonstrated an enhancement of the adrenal glands in multi-injury patients 40 seconds after contrast material application. In contrast to these previous studies, our CT examinations consisted of an arterial phase started with bolus trigger technique and a venous phase, 70 seconds after the arterial phase. According to our clinical impression when performing contrast-enhanced biphasic (arterial and venous) CT in ICU patients, hyperattenuation of the adrenal glands is most commonly seen in the arterial phase. This is in accordance to our results, in Group A subj maximal adrenal enhancement was seen in the arterial phase in all patients and there were no patients with hyperattenuation of the adrenal glands solely in the venous phase. We found a good correlation between objective measurements and subjective evaluation of hyperattenuating glands. Therefore, our results indicate that using subjective evaluation of the arterial phase for assessment of hyperattenuation of the adrenal glands in biphasic contrast-enhanced CT seems reasonable. Larger prospective studies are required to see if arterial phase scanning of the adrenal glands in all ICU patients or in a specific subpopulation of ICU patients may be beneficial.
Invasive ventilation was more frequent in patients with hyperattenuating adrenal glands and thus associated with a poor clinical outcome. This finding has to be expected as ventilation is generally performed in clinically compromised patients. Patient characteristics such as age and gender and laboratory parameters of kidney function, inflammation, and anemia were not associated with hyperattenuating adrenal glands. This demonstrates the heterogeneity of the ICU patient population and the complexity of surgical ICU patients.
Our study has limitations. We did not evaluate precontrast CT scans to ensure the measured hyperattenuation equals true enhancement instead of hemorrhage. Nevertheless, there were no indirect signs of hemorrhage such as enlargement of the adrenal glands. Therefore, absence of hemorrhage can be assumed. Contrast medium injection rate data was not available for every examination. Arterial CT scans are routinely performed with an injection rate of 3e4 mL/s in our department and we believe that a potential bias caused by minor differences in the injection rate is negligible.
The complex ICU patient population included in this study was heterogeneous with different causes of acute deterioration. Although we obtained basic laboratory parameter and ventilation status, we did not evaluate circulatory parameters such as blood pressure and heart rate at time of the CT examination, as these data were not available Values are n/n (%) or mean AE SD (range). in the patients' record. Furthermore, patients' medication at the time of the CT scan was not available and therefore the influence of these drugs on the adrenal enhancement cannot be determined. The IVC is commonly used for comparison when evaluating adrenal enhancement [4, 6, 14] . Nevertheless, contrast enhancement of the IVC in the arterial phase might be inhomogeneous. A threshold of 15 HU for the definition of objective hyperattenuation of the adrenal glands was used to account for this. Objective measurements were performed in nonenlarged adrenal glands. Due to their relatively small size, partial volume effects or inclusion of fat adjacent to the adrenal gland might have influenced our results.
In conclusion, hyperattenuation of the adrenal glands on contrast-enhanced CT examinations of ICU patients with acute clinical deterioration is associated with a high mortality. Our results indicate that subjective evaluation of adrenal hyperattenuation is reasonable. Hyperattenuating adrenal glands might therefore be considered as a predictor of poor clinical outcome in these patients.
